Entering text into the input field will update the search result below
Search for Symbols, analysts, keywords
XORTX Therapeutics Inc.
Stock Price & Overview
2:51 PM 07/11/23
Div Rate (TTM)
Expand For Key Data »
Xortx stock surges ~60% as potential kidney disease drug shows promise in early stage study
XORTX Therapeutics receives Nasdaq non-compliance letter
Xortx stock soars 40% as kidney disease drug shows promise in bridging study
Xortx Therapeutics announces Nasdaq listing; prices $12M public offering
XORTX Therapeutics announces share consolidation
XORTX Therapeutics names Amar Keshri CFO
XORTX announces appointment of CFO
XORTX Therapeutics sets pre-IND meeting with FDA September 10
More News And Analysis »
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.